STOCK TITAN

Brent Sabatini sells restricted shares at VIR (NASDAQ: VIR) — 1,430 noted

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Brent Sabatini filed a Form 144 reporting a proposed sale of Common stock tied to a Restricted Stock Vesting event dated 02/23/2026 for 1430 shares. The excerpt also lists securities recorded as sold during the prior three months: 1530 on 02/13/2026 and 1829 on 02/23/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notice records planned insider sale linked to vesting.

The filing lists a proposed sale of Common stock tied to a Restricted Stock Vesting event on 02/23/2026 for 1430 shares. This is a routine notification under resale rules for insiders.

Cash‑flow treatment and broker/dealer methods are not shown in the excerpt; subsequent SEC filings or a broker disclosure would clarify execution details.

Vesting triggered a resale notice and prior short‑term disposals are listed.

The record ties the 1430‑share notice to a vesting event and lists two prior entries in the three‑month window: 1530 (02/13/2026) and 1829 (02/23/2026). These entries appear as transaction lines rather than broader plan changes.

Reporting focuses on individual transactions; timing and proceeds are not provided in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Brent Sabatini report on Form 144 for VIR?

He reported a proposed sale of Common stock tied to a Restricted Stock Vesting event for 1430 shares on 02/23/2026. The filing also lists two transactions in the prior three months: 1530 on 02/13/2026 and 1829 on 02/23/2026.

Does the Form 144 excerpt show proceeds or buyer details for the VIR shares?

No; the excerpt does not state sale proceeds, broker/dealer names, or execution methods. It lists share counts and dates but omits cash amounts and trading venue details that would show how the sales would be executed.

Is the 1430‑share entry part of compensation for VIR insiders?

Yes; the 1430 shares are linked in the excerpt to a Restricted Stock Vesting event dated 02/23/2026, indicating the shares arose from compensation rather than a market purchase or separate grant.

Do the listed prior transactions change beneficial ownership disclosed elsewhere for VIR?

The excerpt lists prior sale lines (1530 and 1829) but does not provide a post‑transaction beneficial ownership total. It does not state outstanding or remaining holdings tied to the reporting person in this excerpt.
Vir Biotechnology, Inc.

NASDAQ:VIR

View VIR Stock Overview

VIR Rankings

VIR Latest News

VIR Latest SEC Filings

VIR Stock Data

1.35B
126.52M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SAN FRANCISCO